Polyrizon Ltd. PLRZ 深 沪
等待开盘 06-26 09:30:00 美东时间
11.4994
-0.441
-3.69%
华盛通- 最 高13.89
- 今 开11.78
- 成交量 1.31万股
- 最 低 11.11
- 昨 收 11.94
- 总市值 0
- 52周最高 18.20
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.48
- 委 比 -88.68%
- 总股本 --
- 历史最高 18.20
- 量 比 0
- 振 幅 23.28%
- 历史最低 0.0032
- 每 手 1
- 风险率 6.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Polyrizon Signs Agreements With Two Additional U.S. Clinical Sites For Nasarix PL-14 Clinical Study
The study, titled "Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients with Seasonal Allergic Rhinitis," is designed as a multi-center trial in the United
06-08 21:27
Polyrizon Files European Patent Application For Trap & Target Platform Technology
This application focuses exclusively on protecting the Company's advanced intranasal drug delivery system, which is designed to enhance the effectiveness of medications by increasing their residence time and ensuring
04-27 21:29
Polyrizon Starts Key Usability Study Program For Its NASARIX Product Candidate
Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the initiation of a key usability (Human Factors) study
01-22 22:29
Polyrizon Completes Branding Of PL-14 Allergy Blocker As NASARIX, Advancing Commercial Readiness
As part of the branding process, Polyrizon conducted comprehensive trademark screening across the U.S. and European marketsRaanana, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon Ltd.
01-08 21:47
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of GH Research PLC (NASDAQ:GHRS) rose sharply in pre-market trading afte...
01-05 17:27
Polyrizon Explores Revenue-Generating Asset Investments While Advancing Core Biotech Pipeline
Polyrizon Ltd. Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that its Board of Directors has decided
2025-12-29 20:21
What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?
Polyrizon surged in nearly 140% after-hours trading following preclinical data showing its naloxone hydrogel outperforms a marketed spray and a key manufacturing milestone.
2025-12-04 10:52
Gold Down Over 1%; Signet Shares Fall After Q3 Results
U.S. stocks traded higher midway through trading, with the Dow Jones gaining ar...
2025-12-03 01:29
Nasdaq Surges 200 Points; United Natural Foods Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining aroun...
2025-12-02 22:50
Polyrizon Completes Manufacturing Upscaling Milestone For Its Proprietary Nasal-Spray Product Platform
Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, today announced the successful
2025-12-02 20:57
